The Surfacer Inside-Out access catheter system device (Bluegrass Vascular) is safe and effective for patients with thoracic central venous obstruction requiring central venous access. That is the conclusion of the prospective, multicenter SAVE (Surfacer system to facilitate access in venous occlusions) registry, published in the Journal of Vascular and Interventional Radiology (JVIR).
Central venous catheters were successfully placed in 29 of 30 patients (96.7%) with no device-related adverse events or intra- or postprocedural complications reported.
“The SAVE registry achieved its desired objective of confirming the safety and effectiveness of the Surfacer system to gain central venous access in patients with central venous occlusions,” comments Vladimir Matoussevitch, MD, head of the Vascular Access Unit at the University of Cologne in Germany and co-lead author for the paper.
“The publication of the results of the SAVE registry expands and strengthens the clinical evidence confirming the role the Surfacer system has in helping to establish central venous access in patients with venous obstructions,” stated Maurizio Gallieni, MD, director of nephrology and dialysis at the University of Milan in Italy, who was the other co-lead author.
